The Academy of Pharmaceutical Sciences
'Promoting the pharmaceutical sciences'


GlaxoSmithKline expands Canada plant, adds production of topical pain reliever.....           Novartis melanoma combination wins key thumbs-up from cost watchdog NICE after Opdivo shut out.....           Johnson & Johnson's talc supplier inks 11th-hour settlement in California mesothelioma case: report.....           AstraZeneca, shut out of COPD, touts long-term Fasenra asthma data.....           Say hello to Sophia, Novo Nordisk's new online chatbot, available 24/7 for diabetes questions.....           In kickbacks case, CA insurance chief says AbbVie used nurse 'ambassadors' to protect Humira sales.....           With EpiPen competitors bearing down, can Mylan maintain its lead?.....           Pfizer, Glaxo, Novo, Novartis plants unfazed by hurricane, resume production; Merck not as lucky.....           Scientists weigh Zika vaccine challenge study after case count plummets: report.....           Teva, chasing Amgen's Aimovig, scores much-needed FDA approval for migraine drug Ajovy.....           Sanofi, Regeneron pad Dupixent?s case in adolescent eczema ahead of key asthma decision.....           Pfizer 'all in' on advancing next-generation pneumococcal vaccine candidate: CFO.....           With latest data, can AstraZeneca's COPD triple combo rival Glaxo's Trelegy?.....           Pfizer, Glaxo, Novo, Novartis plants unfazed by hurricane, resume production, Merck not as lucky.....           Astellas waltzes into second season sponsorship of ABC?s ?Dancing with the Stars?.....           House quashes Senate amendment to force drug price inclusion in pharma TV ads.....           FiercePharmaAsia?Takeda?s internal discord and U.S. HQ move; Sanofi reorg and more.....           Takeda eyes Shire product sales of up to $5B to pay down debt: Bloomberg.....           Patient groups rebuke CVS on ICER, saying cost-effectiveness reviews discriminate.....           Johnson & Johnson executives say new launches and label expansions will fuel 'above-market' growth through 2021.....           Novartis, Novo, Glaxo and others hunker down as hurricane sweeps in.....           With EU salivating after Humira biosims, analysts start questioning AbbVie's optimism.....           Johnson & Johnson execs say new launches and label expansions will fuel 'above-market' growth through 2021.....           Terrible timing: After Ampyra loss, Acorda's much-needed Inbrija hits snag at FDA.....           Novartis, Novo, Glaxo and others hunker down as hurricane sweeps in.....           Teva attracts attention from pharma, private equity for $500M sale of Medis: Bloomberg.....           J&J execs say new launches and label expansions will fuel 'above-market' growth through 2021.....           Novo Nordisk to slash 400 jobs in R&D unit.....           Cancer Genetics, NovellusDx agree to merge.....           Zealand?s dasiglucagon succeeds in phase 3 trial for severe hypoglycemia.....           Look out, AbbVie. Thanks to Boehringer, your Humira biosimilar defense isn't over yet.....           Johnson & Johnson raises a flag in early-stage lung cancer with first-ever contest in the field.....           Sanofi and Regeneron's Praluent closes in on sales-boosting CV nod.....           Takeda to move U.S. headquarters to Boston, affecting 1,000 employees.....           Israel-based Teva faces age and 'anti-American' bias claims from former U.S. staffer.....           Acorda desperately needs FDA nod for Parkinson's drug as Ampyra generics loom.....           AbbVie strikes tentative deal to settle 4,000-plus AndroGel lawsuits.....           Acorda urgently needs FDA nod for Parkinson's drug as Ampyra generics loom.....           Can Pfizer and Merck KGaA parlay Bavencio combo data into a kidney cancer win?.....           Pfizer suspending operations at U.S. injectables plant as hurricane approaches.....           RSS NEWSFEED....
Welcome to
The Academy of
Pharmaceutical Sciences
 
The Academy of Pharmaceutical Sciences (APS) is the UK-based professional membership body for Pharmaceutical Scientists.

We represent individuals and organisations from around the globe, throughout their development, in the delivery of excellence in the Pharmaceutical Science sector.
 
 
 
 
Latest news

Professional recognition for Pharmaceutical Science Degrees

The Academy of Pharmaceutical Sciences (APS) is delighted to announce that the pharmaceutical science course at the University of Greenwich has become the first APS accredited course having successfully completed the accreditation process set up by the Academy towards the end of 2017.

This is the first time that a pharmaceutical science course has been accredited in the United Kingdom and it is also, we believe, a world first.

Achieving accreditation gives assurance to students and employers that the course meets the high standards required by the Academy and that these standards will be maintained throughout the 5-year period of accreditation.

APS believes that the accreditation process will raise the profile of pharmaceutical sciences in both academia and industry. The discipline is key in the discovery, development and manufacture of new medicines and as such is central to government initiatives to encourage the pharmaceutical industry to maintain and strengthen its strong base here in the UK.

The Academy will continue to work with other stakeholders to build the science base for the ultimate benefit of patients.

 
 
APS events overview

The APS has developed an exciting and informative programme for our events in 2018.

Donít forget to make a note of APS@FIP, linking with the 78th FIP World Congress of Pharmacy and Pharmaceutical Science conference.

Please take a look at our programme, with event summaries, below:

"5 Years of progress in Oral Biopharmaceutics - IMI OrBiTo project and global biopharmaceutics research"
17 September 2018 - AstraZeneca, Granta Park, Cambridge
The APS is pleased to announce this exciting 2 day meeting to review the progress and advances made by the collaborative IMI OrBiTo project . The OrBiTo project started in October 2012 and following a twelve-month non-cost extension phase will finish in October 2018.
Meeting sold out! To learn more, click here

OTHER EVENTS IN DEVELOPMENT
Industrial Insights 2019
Developability for Biologicals
Inhaled Workshop
3D Printing meeting
Basic Biopharmaceutics workshop 

Follow us
 
Upcoming Events
8th Annual MIBio Conference
15 November 2018
APS Additive Manufacturing Symposium
27 March 2019
APS Developability Workshop
17 - 18 April 2019
APS Industrial Insights 2019
25 - 26 April 2019
10th APS International PharmSci conference 2019
11 - 13 September 2019
Job Vacancies
View all Vacancies
Advertise your job vacancies
The APS is grateful for the support of:
Join Us

Join the academy and get discounts on events, post-nominals, latest news and more.

 

The Academy of Pharmaceutical Sciences
Unit Q, Troon Way Business Centre
Humberstone Lane, Leicester, LE4 9HA
Tel: 0116 274 7351, Fax: 0116 274 7365, Email: info@apsgb.org

Terms of use:
The material included on this site is provided for information purposes only, and we make no representations or warranties as to its accuracy. Before relying on this material, you should take care to verify its accuracy, taking professional advice as appropriate.

Privacy Policy:
For details on the data we collect and how we store and process your data please refer to our Privacy Policy.